Skip navigation
Skip navigation

The capacity of schizophrenia and bipolar disorder individuals to make autonomous decisions about pharmacological treatments for their illness in real life: A scoping review

Pons, Enric Vincens; Salvador-Carulla, Luis; Calcedo-Barba, Alfredo; Paz, Silvia; Messer, Thomas; Pacciardi, Bruno; zeller, Scott L.

Description

Abstract Background and aim Having decision making capacity is central to the exercise of autonomy in mental health care. The objective of this scoping review is to summarize the evidence on the capacity of people with schizophrenia or bipolar disorder to make decisions about their treatment in real life to support medical practice. Methods Systematic search of observational studies on the assessment of capacity of patients with schizophrenia, psychosis, or bipolar disorder to make...[Show more]

dc.contributor.authorPons, Enric Vincens
dc.contributor.authorSalvador-Carulla, Luis
dc.contributor.authorCalcedo-Barba, Alfredo
dc.contributor.authorPaz, Silvia
dc.contributor.authorMesser, Thomas
dc.contributor.authorPacciardi, Bruno
dc.contributor.authorzeller, Scott L.
dc.date.accessioned2020-12-18T05:09:42Z
dc.date.available2020-12-18T05:09:42Z
dc.identifier.issn2398-8835
dc.identifier.urihttp://hdl.handle.net/1885/217411
dc.description.abstractAbstract Background and aim Having decision making capacity is central to the exercise of autonomy in mental health care. The objective of this scoping review is to summarize the evidence on the capacity of people with schizophrenia or bipolar disorder to make decisions about their treatment in real life to support medical practice. Methods Systematic search of observational studies on the assessment of capacity of patients with schizophrenia, psychosis, or bipolar disorder to make healthcare and treatment‐related decisions, conducted in any clinical setting published up to January 31, 2020 was performed. Free text searches and medical subject headings in English were combined in PubMed, Scopus, CINAHL, and PsycInfo. Publications were selected as per inclusion and exclusion criteria. The Newcastle‐Ottawa Scale for observational studies was used to assess the quality of publications. Results Thirty publications were reviewed. According to the Newcastle‐Ottawa Scale criteria, the publications reviewed were good quality. Findings showed that more than 70% of schizophrenia and schizoaffective disorder outpatients understood treatment options at the point of making decisions about their illness and healthcare. Patients treated voluntarily had considerably better scores for decisional capacity than those treated involuntarily. The burden of psychiatric symptoms could compromise decisional capacity temporarily. Decision‐making capacity improved over time from admission to discharge from hospital, and with treatment among psychiatry inpatients. Schizophrenia and bipolar disorder patients could be as competent as nonpsychiatric individuals in making decisions about their treatments in everyday life. Conclusions This scoping review provides a body of evidence for healthcare professionals in need of assessing the capacity of schizophrenia and bipolar disorder patients for autonomously decide about their treatments. Decisional capacity judgements should consider variations in capacity over time and be based on the type of decision to be made, the severity of symptoms, and the specific phase of the mental disorder.
dc.description.sponsorshipFerrer funded the development of the study and the writing of the manuscript with an unrestricted grant.
dc.format.mimetypeapplication/pdf
dc.language.isoen_AU
dc.publisherJohn Wiley & Sons, Inc.
dc.rights© 2020 The Authors. Health Science Reports published by Wiley Periodicals LLC.
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceHealth Science Reports
dc.titleThe capacity of schizophrenia and bipolar disorder individuals to make autonomous decisions about pharmacological treatments for their illness in real life: A scoping review
dc.typeJournal article
local.description.notesImported from ARIES
local.identifier.citationvolume3
dc.date.issued2020
local.identifier.absfor111714 - Mental Health
local.identifier.ariespublicationu4102339xPUB519
local.publisher.urlhttps://www.wiley.com/en-gb
local.type.statusPublished Version
local.contributor.affiliationPons , Enric Vincens, Parc Sanitari Sant Joan de Déu, Sant Boi de Llobregat
local.contributor.affiliationSalvador-Carulla, Luis, College of Health and Medicine, ANU
local.contributor.affiliationCalcedo-Barba, Alfredo, Medical School at the Universidad Complutense de Madrid
local.contributor.affiliationPaz, Silvia, SmartWriting4U, Benicassim, Spain
local.contributor.affiliationMesser, Thomas , Department of Psychiatry, Danuviusklinik, Pfaffenhofen, Germany
local.contributor.affiliationPacciardi, Bruno, Psychiatric Unit, Santa Chiara University Hospital, University of Pisa, Pisa, Italy
local.contributor.affiliationzeller, Scott L. , Department of Psychiatry, University of California, California, USA
local.bibliographicCitation.issue3
local.bibliographicCitation.startpage1
local.bibliographicCitation.lastpage13
local.identifier.doi10.1002/hsr2.179
local.identifier.absseo920209 - Mental Health Services
dc.date.updated2020-09-06T08:19:38Z
dcterms.accessRightsOpen Access
dc.provenanceThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
dc.rights.licenseCreative Commons Attribution License
CollectionsANU Research Publications

Download

File Description SizeFormat Image
01_Pons+_The_capacity_of_schizophrenia_2020.pdf1.07 MBAdobe PDFThumbnail


This item is licensed under a Creative Commons License Creative Commons

Updated:  17 November 2022/ Responsible Officer:  University Librarian/ Page Contact:  Library Systems & Web Coordinator